液基薄层细胞学检测结果7972例的宫颈病变诊断分析

Technology of liquid-based Thinprep Cytologic Test in the screening of cervical lesions in 7972 cases

目的:探讨液基薄层细胞技术(TCT)和Bethesda系统(TBS)用于子宫颈细胞学检查的临床价值.方法:2007-01/2009-11本院利用TCT结合TBS分类对7972例患者进行宫颈细胞学检查.结果:7972例涂片中检出异常涂片268例,其中不明确意义的不典型鳞状上皮细胞(ASC-US)204例(2.56%),低度鳞状上皮内病变(LSIL)31例(0.39%),高度鳞状上皮内病变(HSIL)18例(0.23%),宫颈癌5例(0.07%).结论:TCT用于宫颈细胞学诊断,是筛查宫颈癌的重要手段.

AIM：To investigate the clinical value of liquid-based Thinprep Cytologic Test（TCT） technique and the Bethesda System（TBS） in the screening of cervical lesions.METHODS：From January 2007 to February 2009,7972 cases were detected by TCT and TBS.RESULTS：The positive cases were 268 out of 7972,including atypical squamous cells of undetermined significance（ASC-US）were in 204 cases（2.56%）,low grade squamous intraepithelial lesion（LSIL）were in 31 cases（0.38%）and high grade squamous intraepithelial lesion（HSIL）were in 18 cases（0.23%）;cervical carcinoma（CC）were in 5 cases（0.07%）.CONCLUSION：TCT can improve the positive screening rate of cervical lesions,which is an important method in the screening of cervical cancer.